Recent data release may have changed SGMO's future outlook. Sangamo's long-term chart suggests a potential pullback to $4 is a possibility, but that was before a recent data release by the company for updated Phase 1/2 Results for SB-525 . This is an investigational Hemophilia-A gene therapy that showed sustained increased Factor VIII Levels with no reported...
Another pharma company - with amazing correct Elliot 5 waves which you can try to ride. 1. Buy 131.32 2. Take profit: 213 3. SL: 115.90 RISK/REWARD: 5.38, potential profit 62.39%
This stock popped up on my stock screener the other day. I wanted to document this trade in case it ends up going well. What I'm seeing here on the daily is a break above it's 100 then 200 MA. Now we are in this consolidation period with a little coiling action happening within the triangle I've drawn. It's clear price is going to break in an explosive way...
Watching for ABBV to break this wedge and go higher to fill the gap from earnings.
Here is a good resource for more stocks like this www.biopharmcatalyst.com The only stocks I trade currently are biopharma stocks with FDA approvals coming. I know the date there will be price action just need a good entry.
Great Fundamentals. Great Chart. Keeping a tight eye on this one.
Weekly chart: we have the downtrend channel clearly defined on a weekly basis. On a monthly basis we have already had a minimum of swing with a dragon fly bullish, on a daily chart some signs of an incoming uptrend as described in the latest posts...but tomorrow...tomorrow is where we play the game with the last resistence in place at 86.72 dollars. Once we get...
See previous for more detail -- just wanted a fresh chart w/ updated targets and a shorter interval.
I need to do more research before offering a formal opinion, but i bought for TA reasons at 0035 so i wanted to share the chart now that it's making a real move and the cancer drug they make is showing promise. Looks like we could see .01 before a pullback, but the volume is insane so who knows where it ends up.
Just wanted a fresh chart to look at -- Details available via previous idea
Another pharma stock here for those interested. These are often hit or miss, but NEOS has a solid floor and a lot of room to move if it gets going. Worth watching and maybe taking a shot with a small bet (not financial advice -- do we really have to say that when were obviously just finger-painting projections?) haha, GLTA!
As expected KTOV passed the FDA approval time to take some gains and move on to the next one. finance.yahoo.com
I have know about this stock for over a year now, but I have never put the time into charting it. The time is near to buy in, and the patient investor will wait for the MACD to bottom out then buy.
www.biopharmcatalyst.com online.capitalcube.com Looks undervalued to me atm manage your risk GL HF xoxo snoop
Attached is a piece about SWKH in which I discuss the value within the company, and I suggest it as a way of exposure to the healthcare technology sector without the risk. How is that possible? SWKH uses debt investments when making acquisitions in companies. Debt investments are usually the first investments to be paid back in full when a company undergoes...
There is one useful way to determine when a trend is over and that is using a 50% "speedline" of a move. The decline from $400 in $IBB, the IShares Nasdaq Biotechnology Index Fund back in July 2015 and then tumbled 40% to $240 on February 9th, 2016 and later retested $240 on June 27, 2016. The mid-point of that decline is $320 and a line drawn from...
Retest of 72.6 level Time the corrective wave ( range from ~6.7% - 13%...play it safe at 7.5% increase from entry)
get in around 1, sell in the green